The Latest Breaking News from FDA

Eli Lilly is in a buy zone, while weight-loss drug rival Novo Nordisk just forged a lower entry.

Proposed legislation mandates folic acid in masa flour, sparking fears among traditional tortilla makers about costs and cultural impact.

The tool, from telehealth company Ro, lets users report when they find the drug in stock and when there’s a shortage.

As Intuitive Surgical gets FDA clearance for its next-gen robotic surgery system, ISRG stock teases a new breakout.

Government lawyers had told the court flights could go in late June – but then Rishi Sunak called the election

Helpful tool or harmful fad?

The pharma sector is primed for solid growth owing to technological advancements, growing healthcare needs, and a rise in chronic diseases. Given this backdrop, let’s analyze the fundamentals of pharmaceutical stocks Pfizer (PFE) and Bristol-Myers Squibb (BMY) to determine which of these stocks offer better dividend stability and growth. Read…

“The singular most effective and consistent way of extending lifespan in animals is caloric restriction.”

Guardant Health stock jumped Friday after an FDA panel recommended the agency approval Guardant's blood-based colon cancer screening test.